glp 1 agonist and diverticulitis What weight‑loss options are appropriate for an obese patient with diverticulosis who cannot use GLP‑1 receptor agonists?

FDA Approves Oral Semaglutide for Weight Loss

25.56

★★★★☆4.7 (146)

University of Pennsylvania researchers analyzed over 400,000 Reddit posts from nearly 70,000 users across five years and found that semaglutide and tirzepatide users are reporting menstrual irregularities and temperature complaints like chills

29.25

★★★★★5.0 (147)

Tuesday, the FDA announced the approval of 25 mg of Semaglutide, which is taken orally once a day to reduce overweight, maintain weight low long-term and reduce the risk of serious cardiovascular

20.46

★★★★★4.7 (167)

US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss

21.64

★★★★★4.4 (86)

Novo Nordisk Receives FDA Approval for Oral GLP-1 Therapy Wegovy | Mirey Karavetian posted on the topic

27.22

★★★★★4.0 (291)

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

20.59

★★★★★4.3 (104)

Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral semaglutide (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30)

26.09

★★★★★4.3 (251)